Conference Information

Welcome Message

Dear Esteemed Participants,

On behalf of the Organizing Committee, it is our great pleasure to welcome you to the 5th International Conference on Pharmaceutical and Pharma Industry, scheduled to be held on April 15–16, 2026, in the dynamic city of Thiland,Bangkok.

This prestigious event brings together researchers, scientists, academicians, industry experts, and policymakers from around the globe to share the latest advancements, challenges, and future directions in the field of pharmaceutical sciences and the pharma industry. With a strong focus on innovation, regulatory insights, and collaborative opportunities, the conference promises to be a vibrant platform for knowledge exchange and networking.

Dubai, known for its blend of tradition and cutting-edge progress, provides the perfect backdrop for meaningful discussions and global collaboration. We encourage you to take full advantage of this opportunity to connect, learn, and contribute to the advancement of pharmaceutical science and industry.

We look forward to your active participation and wish you a successful and enriching conference experience.

Warm regards,
Gloria Anderson | Program Manager
Contact : +44 7537 171 588

About the Conference

We are delighted to announce the 5th International Conference on Pharmaceutical and Pharma Industry, which will be held on April 15–16, 2026, in the vibrant and cosmopolitan city of Thiland,Bangkok.

This highly anticipated event serves as a global platform for professionals across the pharmaceutical sciences and industry to come together and exchange groundbreaking ideas, emerging trends, and practical insights. The conference aims to foster collaboration between academia, industry leaders, regulatory authorities, and research institutions to address the most pressing challenges and innovations shaping the future of pharmaceuticals.

Key highlights of the conference include:

Cutting-edge scientific sessions and keynote speeches from renowned experts
In-depth panel discussions and interactive workshops
Poster presentations and abstract sessions showcasing ongoing research
Networking opportunities with global pharma professionals and innovators
Insights into regulatory affairs, drug development, formulation, and manufacturing

Whether you're involved in drug discovery, regulatory science, clinical trials, pharmacovigilance, or pharmaceutical technology, this conference offers a unique opportunity to engage with thought leaders and peers from around the world.

Join us in Thiland, a global hub for innovation and business, and be part of this transformative event shaping the future of the pharmaceutical landscape.

Scientific Sessions

SESSION 1. Dominance of Small-Molecule Drugs

Small-molecule pharmaceuticals have long served as a cornerstone of therapeutic treatment due to their versatility and effectiveness. This segment will explore current trends in small-molecule drug development, emphasizing innovations in drug design and targeted therapies, particularly in the field of oncology. It will also cover advancements in oral drug delivery systems, key safety considerations, and evolving global market dynamics.

Sub-Sessions:

Innovations in Drug Design
Targeted Therapies in Oncology
Oral Drug Delivery Systems
Small-Molecule Drug Safety
Global Market Trends

Related Conference:

Related Association:

American Pharmacists Association | American Society of Health-System Pharmacists | Academy of Managed Care Pharmacy | American College of Clinical Pharmacy | National Community Pharmacists Association |American Association of pharmaceutical Scientists |Association for Accessible Medicines |pharmaceutical Research and Manufacturers of America |International pharmaceutical Federation |European Federation of pharmaceutical Industries and Associations

Related Journals:

SESSION 2. Rise of Biologics

Biologic therapies have profoundly reshaped patient care, particularly in oncology, immunology, and the treatment of rare diseases. This discussion will highlight recent advancements in biologics, including innovations in monoclonal antibody development and major breakthroughs in gene therapy. It will also examine challenges associated with biologic drug development, the growing role of biosimilars, and the potential of combination therapies to improve treatment effectiveness.

Sub-Sessions:

Monoclonal Antibodies in Disease Treatment
Gene Therapy Breakthroughs
Biosimilars: The Future of Biologics
Biologic Drug Development Challenges
Biologic Combination Therapies

Related Conference:

Related Association:

Related Journals:

SESSION 3. Personalized Medicine

Precision medicine has transformed healthcare by customizing treatments to individual patient profiles. This session will highlight recent advances in personalized therapies, focusing on the role of genomic profiling and biomarkers in drug development. It will also address the challenges of implementing personalized medicine and underscore the importance of patient-centric approaches in improving patient outcomes.

Sub-Sessions:

Genomic Profiling in Drug Development
Biomarkers in Precision Medicine
Pharmacogenomics
Challenges in Personalised Medicine
Patient-Centric Approaches

Related Conference:

Related Association:

Related Journals:

SESSION 4. Outsourcing Trends

The pharmaceutical industry is placing growing reliance on Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to deliver specialized services. This segment will analyze current outsourcing trends, emphasizing the contributions of CMOs and CROs to drug development. It will also address critical areas including quality assurance, regulatory compliance, cost efficiency, risk management in outsourced projects, and the effects of global sourcing.

Sub-Sessions:

The Role of CMOs and CROs in Drug Development
Quality Assurance and Regulatory Compliance
Cost-Efficiency in Outsourcing
Risk Management in Outsourced Projects
Global Sourcing Trends

Related Conference:

Related Association:

Related Journals:

SESSION 5. Artificial Intelligence in Pharma

Artificial Intelligence (AI) is reshaping drug discovery, clinical trials, and operational efficiency across the pharmaceutical industry. This session will highlight the role of AI in accelerating development processes, including its applications in drug discovery and clinical trial design. It will also explore improvements in operational efficiency, along with regulatory considerations and the ethical implications of using AI in healthcare.

Sub-Sessions:

AI in Drug Discovery
AI for Clinical Trial Design and Monitoring
Operational Efficiency and AI
AI in Regulatory Affairs
Ethical Considerations of AI

Related Conference:

Related Association:

Related Journals:

SESSION 6. Big Data Analytics

The rise of big data has significantly transformed the healthcare and pharmaceutical development landscape. This discussion will explore the use of big data across various applications, including data-driven drug discovery and predictive analytics for clinical trials. It will also focus on regulatory and ethical challenges associated with big data, as well as its integration with AI.

Sub-Sessions:

Data-Driven Drug Discovery
Predictive Analytics for Clinical Trials
Patient Data Utilisation
Regulatory and Ethical Issues in Big Data
AI and Big Data Integration

Related Conference:

Related Association:

Related Journals:

SESSION 7. Regulatory Challenges

Pharmaceutical companies operate within a constantly evolving regulatory landscape that presents significant challenges. This segment will focus on key regulatory hurdles in the drug approval process, including global harmonization efforts. It will also explore strategies for navigating FDA and EMA requirements, regulatory flexibility during public health emergencies, and the impact of regulations on pharmaceutical manufacturing.

Sub-Sessions:

Regulatory Hurdles in Drug Approval
Global Regulatory Harmonisation
Navigating FDA and EMA Approval Processes
Regulatory Flexibility in Emergencies
Regulatory Impact on Manufacturing

Related Conference:

Related Association:

Related Journals:

SESSION 8. Emerging Markets

As global pharmaceutical markets continue to expand, emerging economies offer both substantial opportunities and notable challenges. This session will examine growth strategies for entering these markets, with a focus on navigating diverse regulatory environments and adapting drug development processes. It will also highlight the role of strategic partnerships and the growing demand for biologics in emerging regions.

Sub-Sessions:

Pharma Market Entry Strategies
Regulatory Landscape in Emerging Economies
Adapting Drug Development for Emerging Markets
Strategic Partnerships in Emerging Markets
Market Demand for Biologics in Emerging Regions

Related Conference:

Related Association:

Related Journals:

SESSION 9. Extended Reality (XR) Technologies

Extended Reality (XR) is transforming pharmaceutical research, training, and patient care. This discussion will highlight the latest applications of XR in drug discovery and research, as well as its role in clinical trials and patient education. It will also examine the use of XR in training healthcare professionals and supporting regulatory compliance, along with future prospects for XR in the pharmaceutical industry.

Sub-Sessions:

XR in Drug Discovery and Research
XR for Clinical Trials and Patient Education
Training Healthcare Professionals with XR
XR in Regulatory Compliance
The Future of XR in Pharma

Related Conference:

Related Association:

Related Journals:

SESSION 10. Innovations in Drug Delivery Systems

Recent advances in drug delivery methodologies are significantly improving the effectiveness of therapies and patient adherence. Innovative approaches such as nanotechnology, biodegradable delivery systems, and advanced injection techniques are being developed to enhance patient outcomes. These innovations aim to optimize drug formulation and administration, resulting in more effective treatments and improved patient compliance. Additionally, this discussion will explore the potential of these technologies to address specific challenges in medication delivery and patient care.

Sub-Sessions:

Nanotechnology in Drug Delivery
Biodegradable Drug Delivery Systems
Advanced Injection Systems
Oral Drug Delivery Innovations
Long-Acting Drug Delivery

Related Conference:

Related Association:

Related Journals:

SESSION 11. Sustainability Practices

Sustainability is becoming increasingly critical in pharmaceutical manufacturing and supply chains. As global demand for medicinal products continues to grow, pharmaceutical companies are under greater pressure to reduce their environmental impact and adopt greener practices. This discussion will explore strategies for minimizing waste, improving energy efficiency, and ensuring the sustainable sourcing of materials.

Sub-Sessions:

Green Manufacturing Technologies
Sustainable Packaging Solutions
Supply Chain Sustainability
Regulatory Incentives for Sustainability
Circular Economy in Pharma

Related Conference:

Related Association:

Related Journals:

SESSION 12. Cell and Gene Therapies

Cell and gene therapies are transforming treatment approaches for genetic disorders, cancers, and rare diseases. This discussion will highlight recent breakthroughs in gene-editing technologies, particularly CRISPR, and their potential to offer cures for conditions once considered untreatable. It will also examine the regulatory and ethical challenges associated with these pioneering therapies.

Sub-Sessions:

CRISPR and Gene Editing Technologies
Stem Cell Therapies
Regulatory Landscape for Gene Therapies
Ethical Considerations in Gene Editing
Patient Access and Affordability

Related Conference:

Related Association:

Related Journals:

SESSION 13. Digital Therapeutics

Digital therapeutics (DTx) offer innovative approaches for managing chronic diseases through software-driven interventions. This session will highlight how digital health solutions complement traditional therapies, improve patient outcomes, and advance personalized care. It will also address regulatory challenges and the integration of DTx into existing healthcare systems.

Sub-Sessions:

Clinical Applications of Digital Therapeutics
Regulatory Landscape for Digital Health
Patient Engagement with Digital Health
Data Privacy and Security in Digital Therapeutics
Integration with Traditional Therapies

Related Conference:

Related Association:

Related Journals:

SESSION 14. Pricing Pressures and Market Access

Amid rising drug prices and growing demand for affordable healthcare, pharmaceutical companies face mounting pricing pressures. This session will explore strategies to improve access to life-saving medications while navigating the complex landscape of global pricing and reimbursement policies.

Sub-Sessions:

· Global Pricing Strategies

· Reimbursement Models and Access to Medicines

· Health Technology Assessments (HTA)

· Negotiating with Payers and Governments

· Price Transparency and Public Perception

Related Conference:

Related Association:

Related Journals:

Market Analysis

Market Growth and Projections

Global Market Growth: The global pharmaceuticals market is projected to expand from $1,585.05 billion in 2022 to $2,401.22 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.1%.

Regional Contribution:

North America: As of 2023, this region contributes approximately 53.3% of global pharmaceutical sales.
Asia-Pacific: Anticipated to exhibit the highest growth rate, with a projected CAGR exceeding 8% due to increasing healthcare investments.

Sector Performance

Indian Pharmaceutical Market (IPM):
In October 2024, the Indian pharmaceutical market recorded a value growth of 6.1%, achieving a total turnover of over â‚¹2.18 trillion, despite experiencing a negative volume growth of 1.8%.

Global Pharmaceutical Output:
Forecasts indicate a global pharmaceutical output increase of approximately 3% in 2024.

Key Trends Influencing the Market

Small-Molecule Drugs: Expected to account for over 54.9% of global pharmaceutical sales, maintaining their dominance due to cost-effectiveness.
Biologics Growth: The adoption of biologic therapies is rising, significantly contributing to market expansion.
Outsourcing Trends: The trend towards outsourcing drug development is growing, with companies reporting operational cost savings of up to 30-40%.
Emerging Markets Focus: Countries such as India and China are pivotal markets, with China’s pharmaceutical production projected to grow by approximately 7.7% in 2024.
Technological Advancements: The adoption of AI and machine learning in drug discovery is expected to enhance efficiency by up to 50%, improving treatment outcomes.

Challenges Facing the Industry

R&D Costs: The average cost to bring a new drug to market is estimated at around $2.6 billion, with R&D expenditures rising by approximately 5-10% annually.
Regulatory Compliance Costs: Compliance with regulatory standards can account for up to 25% of total development costs.
Pricing Pressures: Governments are advocating for lower drug prices, which could lead to potential revenue reductions of 15-20% for certain products.

Conclusion

The pharmaceutical industry is on a growth trajectory, with anticipated increases driven by technological advancements and expanding markets, particularly in the Asia-Pacific region. However, companies must strategically manage R&D costs and regulatory challenges that could impact profitability and market access.

5th International Conference on
Pharmaceutical and Pharma Industry

Quick Links

Theme: Digitize Operations. Strengthen Supply Chains. Shape Tomorrows Pharma

Conference Information

Welcome Message

About the Conference

Scientific Sessions

Market Analysis